Asia-Pacific Diabetes Care Devices Market - Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia-Pacific Diabetes Care Devices Market - Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Sep 2021
  • Asia-Pacific
  • 150 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia Pacific Diabetes Care Devices Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2022 –2028
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 39.60 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services
  • Dexcom
  • Medtronic

Asia-Pacific Diabetes Care Devices Market, By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Institutional Sales, Retail Sales), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Diabetes Care Devices Market Market Analysis and Insights : Asia-Pacific Diabetes Care Devices Market

The Asia-Pacific diabetes care devices market is expected to witness market growth at a rate of 7.60% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Asia-Pacific diabetes care devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence for patients with diabetes and the advancement of the demand for a healthier, quicker and efficient method of diagnosing and treating diabetes is escalating the growth of Asia-Pacific diabetes care devices market.

Diabetes is known to be a disorder that cannot create insulin formed in the serum in the pancreas. Augmented blood sugar persuades untreated diabetes. Diabetes treatments are utilized for diabetes diagnosis in particular. Treatment strategies for diabetes are being used to stimulate glucose in the body.

 Major factors that are expected to boost the growth of the Asia-Pacific diabetes care devices market in the forecast period are the rise in the prevalence of patients with diabetes. Furthermore, the advancement of diabetes technology is further anticipated to propel the growth of the Asia-Pacific diabetes care devices market. On the other hand, the dearth of compensation or stringent rules is further projected to impede the growth of the Asia-Pacific diabetes care devices market in the timeline period.

In addition, the growing alertness of diabetes care devices will further provide potential opportunities for the growth of the Asia-Pacific diabetes care devices market in the coming years. However, the decrease in the expenses per person on diabetes which might further challenge the growth of the Asia-Pacific diabetes care devices market in the near future.

This Asia-Pacific diabetes care devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific diabetes care devices market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Asia-Pacific Diabetes Care Devices Market Scope and Market Size

The Asia-Pacific diabetes care devices market is segmented on the basis of product and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

  • On the basis of product, the Asia-Pacific diabetes care devices market is segmented into blood glucose monitoring devices and insulin delivery devices. Blood glucose monitoring devices is further sub segmented into testing strips, blood glucose meters lancets and others. Blood glucose meters is further sub segmented into self-monitoring blood glucose meters and continuous blood glucose monitoring devices. Insulin delivery devices is further sub segmented into insulin syringes, insulin pens, insulin pumps, insulin jet injectors and others.
  • On the basis of distribution channel, the Asia-Pacific diabetes care devices market is segmented into institutional sales and retail sales. Institutional sales is further sub segmented into hospitals, clinics and others. Retail sales is further sub segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Asia-Pacific Diabetes Care Devices Market Country Level Analysis

The Asia-Pacific diabetes care devices market is analyzed, and market size insights and trends are provided by country, product and distribution channel as referenced above.      

The countries covered in the Asia-Pacific diabetes care devices market report are the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China dominates the Asia-Pacific diabetes care devices market due to the rise in the incidence of diabetic patients. Furthermore, the growth of the diabetic population will further boost the growth of the Asia-Pacific diabetes care devices market in the region during the forecast period.

The country section of the Asia-Pacific diabetes care devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The Asia-Pacific diabetes care devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Asia-Pacific diabetes care devices market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific diabetes care devices market. The data is available for the historic period 2010-2019.

Competitive Landscape and Asia-Pacific Diabetes Care Devices Market Share Analysis

The Asia-Pacific diabetes care devices market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the Asia-Pacific diabetes care devices market.

The major players covered in the Asia-Pacific diabetes care devices market report are Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Dexcom, Inc., Medtronic, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation., Rossmax International Ltd., Trividia Health, Inc., Novo Nordisk A/S and Sanofi among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Asia-Pacific Diabetes Care Devices Market, By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices), Distribution Channel (Institutional Sales, Retail Sales), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028 .
The Asia Pacific Diabetes Care Devices Market size was valued at USD 0.00 USD Billion in 2021.
The Asia Pacific Diabetes Care Devices Market is projected to grow at a CAGR of 7.6% during the forecast period of 2022 to 2028.
The major players operating in the market include Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services , Dexcom , Medtronic, ARKRAY , Ascensia Diabetes Care Holdings AG, AgaMatrix, Bionime Corporation, Rossmax International Ltd, Trividia Health , Novo Nordisk A/S, Sanofi .